首页 正文

Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib

{{output}}
Background: Vitiligo is a chronic autoimmune disorder marked by the loss of melanocytes, causing depigmented patches across the skin. Affecting up to 2% of the global population, vitiligo presents significant psychological impact... ...